Arvinas, Inc. Stock Performance

Open $7.47	Prev. Close $7.52	Circuit Range N/A
Day Range $7.47 - $7.72	Year Range $7.00 - $14.28	Volume 35,160
Average Traded $7.64

Arvinas, Inc. Share Price Today

As of 10 October 2026, Arvinas, Inc.'s share price is $7.65. The stock opened at $7.47, compared to its previous close of $7.52. During today's trading session, Arvinas, Inc.'s share price traded between $7.47 and $7.72, with an average price of $7.60. Over the past 52 weeks, the stock has recorded a high of $14.28 and a low of $7.00. In terms of performance, Arvinas, Inc.'s share price has declined by 22.65% over the last six months and is down 24.56% on a year-on-year basis.

Arvinas, Inc. Share Price Chart

$7.47$7.72

Arvinas, Inc. Stock Fundamentals & Key Indicators

Market Cap $542.38M	PE Ratio (TTM) 52.80	Dividend Yield 0.00%
EPS (TTM) $0.14	Revenue (TTM) $262.60B	Return On Equity (TTM) 1.65%
Profit Margin -30.77%	Debt to Equity 0.00	Quarterly Earnings Growth YoY 582.62%

Arvinas, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$41.90	$9.50	$15.60	$249.70
Net Profit	-$35.10	-$67.40	-$57.60	$169.40
Net Profit Margin	-83.77%	-709.47%	-369.23%	67.84%
Income Change	N/A	-92.02%	14.54%	394.10%

Arvinas, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$131.40	$78.50	$263.40	$262.60
Net Profit	-$282.50	-$367.30	-$198.90	-$80.80
Net Profit Margin	-214.99%	-467.90%	-75.51%	-30.77%
Income Change	N/A	-30.02%	45.85%	59.38%

About Arvinas, Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Arvinas, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$7.75	$7.65	-0.91%
Sep 2026	$9.13	$7.72	-16.40%
Aug 2026	$8.17	$9.23	+15.02%
Jul 2026	$8.42	$8.03	-3.50%
Jun 2026	$8.99	$8.32	-7.35%
May 2026	$10.02	$8.98	-9.20%
Apr 2026	$10.82	$9.89	-6.79%
Mar 2026	$13.21	$10.61	-20.05%
Feb 2026	$13.22	$13.27	-1.04%
Jan 2026	$11.71	$13.41	+12.97%
Dec 2025	$12.24	$11.87	-5.72%
Nov 2025	$10.07	$12.59	+24.16%

ARVN Share Price FAQs

What is Arvinas, Inc. share price today?

Arvinas, Inc. share price today is $7.65 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Arvinas, Inc. stock?

The 52 week high of Arvinas, Inc. stock is $14.28, while the 52 week low is $7.00 as of 10 Oct '26.

What is ARVN's market capitalisation today?

ARVN market capitalisation is $542.38M as of October 10, 2026, at 4:42 am IST.

What is ARVN's net income for the last quarter?

ARVN's net income for the last quarter is 169.40B USD.

What is the 5 year returns of ARVN?

The 5 year returns of ARVN is -91.17% as on 10 Oct '26.

What is the high & low stock price of ARVN today?

ARVN stock price hit a high of $7.72 and low of $7.47 as of 10 Oct '26.

Can I buy ARVN shares in India?

Yes. You can buy ARVN in India by opening an international trading account.